医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

iMDsoft is Proud to be The Vendor of Choice for Computerising Critical Care across Health Networks

2015年05月11日 PM05:15
このエントリーをはてなブックマークに追加


 

DÜSSELDORF, Germany

iMDsoft is proud to be the vendor of choice for governments and hospital chains seeking a critical care clinical information system for multiple sites. The company offers unique solutions designed to facilitate large scale deployments, and has a proven track record of successful region-wide projects all over the world.

Four large scale projects have been signed over the past 18 months: New South Wales Health in Australia, Uppsala County Council and Västerbotten County Council in Sweden and Helse Nord RHF in Norway. “Having an electronic record improves the quality of medication management and provides our staff with advanced clinical decision support and a better overview of patient and treatment information,” said Lars Vorland, CEO of Helse Nord RHF.

MetaVision provides a single integrated electronic health record which can be accessed across departments and hospitals, giving clinicians the platform to coordinate care for their sickest patients and the data they need to make informed decisions about the best course of treatment. MetaVision‘s distributed database architecture enables networks to maintain uniformity and enforce clinical best practices across institutions. Using centralised configuration management, MetaVision helps networks enhance operational efficiency through access to common data with consistent terminology. The system also has the flexibility to meet the diverse requirements of each installed unit while preserving standardisation across sites.

iMDsoft has agreements with health networks in Denmark, Australia, Canada, Sweden, Norway, Austria and the US. Here is a look at some recent projects:

  • Sjælland region, Denmark: Live throughout the entire public health system, in seven hospitals
  • Queensland Health, Australia: Enterprise agreement that covers ICUs across the state’s network of public hospitals
  • Uppsala County Council, Sweden: Chose MetaVision for their high acuity environment county-wide
  • Helse Nord RHF, Norway: Chose MetaVision for the entire region, for over 2000 beds
  • New South Wales Health, Australia: Biggest public health system in Australia; Agreement to install MetaVision throughout the state’s ICUs
  • Västerbotten County Council, Sweden: Chose MetaVision for all their critical care departments

“The implementation of MetaVision has improved the quality of clinical documentation throughout the region. This data can now be used to deliver better care and to manage patients more effectively,” said Dorthe Bruun Jacobsen, Head Nurse at Køge Anæstesiologisk Afdelning and clinical lead of the Sjælland project.

“With a unique architecture that enables efficient software deployments across regions, MetaVision can meet the needs of large scale projects,” said Lars-Oluf Nielsen, CEO of iMDsoft. “The system is adapted for local regulations and reporting requirements for each region, and has the flexibility to meet the specific needs of any health organisation.”

About iMDsoft

iMDsoft is a leading provider of Clinical Information Systems for critical, perioperative, and acute care environments. The company’s flagship family of solutions, the MetaVision Suite, was first implemented in 1999. Hospitals and health networks worldwide use MetaVision to improve care quality and enhance financial results. The system promotes compliance with protocols and best practices, streamlines reporting and supports clinical research. To learn more about iMDsoft, visit www.imd-soft.com.

CONTACT

iMDsoft
Anne Belkin, +781-4495567
Director of Marketing
anne.belkin@imd-soft.com

同じカテゴリーの記事 

  • EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market
  • EMSケーゲルトレーナー BODYDOCTOR、Femcareのグローバル市場でK-HEALTH CAREに注目が集まる
  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024